|Bid||0.0000 x N/A|
|Ask||0.0000 x N/A|
|Day's Range||0.0055 - 0.0055|
|52 Week Range||0.0005 - 0.0270|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Montreal, Quebec--(Newsfile Corp. - July 30, 2021) - Elixxer Ltd. (TSXV: ELXR) (OTCQB: ELIXF) ("Elixxer" or the "Company) is pleased to announce that, further to it press release dated June 24, 2021 in which it was announced that Little Green Pharma ("LGP") had successfully acquired a CACP/GMP medical cannabis facility in Denmark, LGP has also completed a AUD$27.2 million equity placement with existing institutional and sophisticated investors, including a AUD$15 million commitment ...
Montréal, Quebec--(Newsfile Corp. - July 6, 2021) - Elixxer Ltd. (TSXV: ELXR) (OTCQB: ELIXF) ("Elixxer" or the "Company) announces that it intends to file with the TSX Venture Exchange (the "TSXV") a Notice of Intention to Make a Normal Course Issuer Bid. Pursuant to the proposed normal course issuer bid (the "NCIB"), the Company proposes to purchase for cancellation up to an aggregate of 56,050,801 of its issued and outstanding common shares, representing ...
It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we'd be...